Quantitative susceptibility mapping of deep brain nuclei in 22q11.2 deletion syndrome
Frontiers in Psychiatry · 09.01.2026 · 16
DOI: 10.3389/fpsyt.2025.1652700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 09.01.2026. Verfasst von Nestor Muñoz und 15 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Imaging Center, Pontificia Universidad de Chile, Santiago, Chile. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
22q11.2 Deletion Syndrome (22q11.2 DS) confers a high risk to dopamine-related disorders such as schizophrenia and Parkinson’s disease. These disorders have recently been associated with abnormal iron concentrations in deep brain nuclei. In this study we hypothesized that abnormal iron concentrations may also appear in deep brain nuclei of individuals with 22q11.2 DS.
Methods
We analyzed iron concentrations in four dopamine-related nuclei (caudate, putamen, substantia nigra, and globus pallidus) of 32 individuals, including adolescents and adults, carriers of the 22q11.2 DS and 49 healthy controls. For all individuals, we characterized iron concentrations in each region by quantifying R2* values and using a recently developed technique called Quantitative Susceptibility Mapping (QSM). We used linear mixed models to analyze potential differences between 22q11.2 DS individuals and our control group, considering brain region, age, sex, laterality, volume size, and framewise-displacement as fixed-effect covariates and individuals’ intercepts as random effects.
Results
All individuals showed age-related increases in R2* values and susceptibility within dopaminergic nuclei (caudate, putamen, and substantia nigra). However, individuals with 22q11.2 DS showed a significantly lower rate of increase compared to healthy control group. This suggests that, over time, individuals with 22q11.2 deletion syndrome accumulate less iron in these nuclei than healthy controls.
Conclusions
Individuals with 22q11.2 DS present lower iron accumulation in dopaminergic areas, such as substantia nigra, caudate and putamen, relative to healthy controls. These findings suggest a possible association between a dopaminergic dysfunction and abnormal iron accumulation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Imaging Center, Pontificia Universidad de Chile, Santiago, Chile.
- Department of Electrical Engineering, Pontificia Universidad de Chile, Santiago, Chile.
- Millennium Institute for Intelligent Healthcare Engineering, Santiago, Chile.
- Biomedical Engineering, Faculty of Engineering, Universidad de Santiago de Chile, Santiago, Chile.
- Department of Psychiatry, Pontificia Universidad Catolica de Chile, Santiago, Chile.
- Department of Psychiatry and Mental Health, Clinical Hospital, Universidad de Chile, Santiago, Chile.
Zitieren
APA
Muñoz, N., García, M., Cuiza, A., Tepper, A., Vásquez, J., Ramirez-Mahaluf, J. P., Barbagelata, D., Aguirre, J., Maldonado, M. E., Ornstein, C., Fritsch, R., Repetto, G., Milovic, C., Andia, M. E., Crossley, N. A., & Tejos, C. (2026). Quantitative susceptibility mapping of deep brain nuclei in 22q11.2 deletion syndrome. Frontiers in Psychiatry, 16. https://doi.org/10.3389/fpsyt.2025.1652700
Vancouver
Muñoz N, García M, Cuiza A, Tepper A, Vásquez J, Ramirez-Mahaluf JP, et al. Quantitative susceptibility mapping of deep brain nuclei in 22q11.2 deletion syndrome. Frontiers in Psychiatry. 2026;16. doi:10.3389/fpsyt.2025.1652700
BibTeX
@article{Muoz2026,
author = {Muñoz, Nestor and García, Marisleydis and Cuiza, Analía and Tepper, Angeles and Vásquez, Javiera and Ramirez-Mahaluf, Juan Pablo and Barbagelata, Daniella and Aguirre, Juan and Maldonado, María Elisa and Ornstein, Claudia and Fritsch, Rosemarie and Repetto, Gabriela and Milovic, Carlos and Andia, Marcelo E and Crossley, Nicolas A and Tejos, Cristian},
title = {Quantitative susceptibility mapping of deep brain nuclei in 22q11.2 deletion syndrome},
journal = {Frontiers in Psychiatry},
year = {2026},
volume = {16},
doi = {10.3389/fpsyt.2025.1652700}
}
EUVIMED